In the last trading session, 1.99 million Sarepta Therapeutics Inc (NASDAQ:SRPT) shares changed hands as the company’s beta touched 0.84. With the company’s per share price at $60.85 changed hands at -$0.66 or -1.07% during last session, the market valuation stood at $5.98B. SRPT’s last price was a discount, traded about -184.72% off its 52-week high of $173.25. The share price had its 52-week low at $48.01, which suggests the last value was 21.1% up since then. When we look at Sarepta Therapeutics Inc’s average trading volume, we note the 10-day average is 1.75 million shares, with the 3-month average coming to 1.93 million.
Analysts gave the Sarepta Therapeutics Inc (SRPT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.40. If we narrow down to specifics, the data shows that 1 out of 17 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 6 recommended SRPT as a Hold, 10 felt it is a Buy and 0 rated the stock as Underweight.
Sarepta Therapeutics Inc (NASDAQ:SRPT) trade information
Instantly SRPT was in red as seen at the end of in last trading. With action 2.60%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -49.95%, with the 5-day performance at 2.60% in the green. However, in the 30-day time frame, Sarepta Therapeutics Inc (NASDAQ:SRPT) is -13.58% down. Looking at the short shares, we see there were 6.62 million shares sold at short interest cover period of 1.91 days.
The consensus price target for the stock as assigned by Wall Street analysts is 180, meaning bulls need an upside of 66.19% from its current market value. According to analyst projections, SRPT’s forecast low is 110 with 202 as the target high. To hit the forecast high, the stock’s price needs a -231.96% plunge from its current level, while the stock would need to soar -80.77% for it to hit the projected low.
The 2025 estimates are for Sarepta Therapeutics Inc earnings to increase by 70.20%, but the outlook for the next 5-year period is at 92.16% per year.
SRPT Dividends
Sarepta Therapeutics Inc is expected to release its next quarterly earnings report on 2025-Feb-25.
Sarepta Therapeutics Inc (NASDAQ:SRPT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 4.41% of Sarepta Therapeutics Inc shares while 91.72% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 95.95%. There are 91.72% institutions holding the Sarepta Therapeutics Inc stock share, with BLACKROCK INC. the top institutional holder. As of 2024-06-30, the company held 10.9117% of the shares, roughly 10.32 million SRPT shares worth $1.63 billion.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 9.5496% or 9.04 million shares worth $1.43 billion as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were GROWTH FUND OF AMERICA and iShares Trust-iShares Core S&P Mid-Cap ETF . With 3.15 shares estimated at $191.67 million under it, the former controlled 3.25% of total outstanding shares. On the other hand, iShares Trust-iShares Core S&P Mid-Cap ETF held about 3.22% of the shares, roughly 3.12 shares worth around $189.85 million.
